Evidence map›Paper›PMID 33149933›Full record

ArticleRegenerative biomaterials2020

Improved the biocompatibility of cancellous bone with compound physicochemical decellularization process.

You Ling, Weikang Xu, Lifeng Yang, Changyan Liang, Bin Xu

Open access · goldAbstract read
In one paragraph

Article in Regenerative biomaterials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Recent advances in regenerative biomaterials.Regenerative biomaterials · 2022
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

You LingNational Engineering Research Center for Human Tissue Restoration and Function Reconstruction, School of Materials Science and Engineering,  South China University of Technology, Guangzhou Higher Education Mega Centre, Panyu District, Guangzhou, Guangdong 510006, China.
Weikang XuDepartment of Scientific Research, National Engineering Research Center for Healthcare Devices, Guangdong Key Lab of Medical Electronic Instruments and Polymer Material Products, Guangdong Institute of Medical Instruments, Guangdong Academy of Sciences, No. 1307 Guangzhou Avenue Central, Tianhe District, Guangzhou, Guangdong 510500, China.
Lifeng YangDepartment of Biosecurity Evaluation, Guangdong Medical Devices Quality Surveillance and Test Institute, No. 1 Guangpu West Road, Huangpu District, Guangzhou, Guangdong 510663, China.
Changyan LiangDepartment of Gynecology, Third Affiliated Hospital of Sun Yat-sen University, No.600 Tianhe Road, Tianhe District, Guangzhou 510630, China.
Bin XuNational Engineering Laboratory for Regenerative Implantable Medical Devices, R&D Center, Grandhope Biotech Co., Ltd, Guangzhou, Guangdong 510530, China.
Guangzhou Regenerative Medicine and Health Guangdong Laboratory · CNGuangdong Academy of Sciences · CNThird Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the unique microstructures and components of extracellular matrix (ECM), decellularized scaffolds had been used widely in clinical. The reaction of the host toward decellularized scaffolds depends on their biocompatibility, which should be satisfied before applied in clinical. The aim of this study is to develop a decellularized xenograft material with good biocompatibility for further bone repair, in an effective and gentle method. The existing chemical and physical decellularization techniques including ethylene diamine tetraacetic acid (EDTA), sodium dodecyl sulfate (SDS) and supercritical carbon dioxide (SC-CO

Indexed as

biocompatibilitycancellous boneextracellular matrixphysicochemical decellularization

Identifiers

PMID33149933
PMCPMC7597803
OpenAlexW3082216952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.